Advisor Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.08M | Buy |
3,555
+1,061
| +43% | +$321K | 0.08% | 278 |
|
|
2022
Q1 | $1.02M | Buy |
2,494
+127
| +5% | +$52.1K | 0.06% | 295 |
|
|
2021
Q4 | $1.11M | Buy |
2,367
+217
| +10% | +$102K | 0.07% | 281 |
|
|
2021
Q3 | $913K | Sell |
2,150
-124
| -5% | -$52.7K | 0.06% | 296 |
|
|
2021
Q2 | $817K | Sell |
2,274
-114
| -5% | -$41K | 0.05% | 348 |
|
|
2021
Q1 | $673K | Buy |
2,388
+52
| +2% | +$14.7K | 0.05% | 393 |
|
|
2020
Q4 | $662K | Buy |
2,336
+199
| +9% | +$56.4K | 0.05% | 362 |
|
|
2020
Q3 | $587K | Buy |
2,137
+129
| +6% | +$35.4K | 0.05% | 342 |
|
|
2020
Q2 | $456K | Buy |
2,008
+192
| +11% | +$43.6K | 0.04% | 392 |
|
|
2020
Q1 | $276K | Buy |
1,816
+160
| +10% | +$24.3K | 0.03% | 463 |
|
|
2019
Q4 | $260K | Sell |
1,656
-3
| -0.2% | -$471 | 0.03% | 533 |
|
|
2019
Q3 | $235K | Buy |
+1,659
| New | +$235K | 0.03% | 567 |
|